December 6, 2022


All the News All the Time

Biogen names Christopher Viehbacher as CEO By Reuters

1 min read

© Reuters. FILE PHOTO: A test tube is seen in front of displayed Biogen logo in this illustration taken, December 1, 2021. REUTERS/Dado Ruvic/Illustration/File Photo

(Reuters) -Biogen Inc on Thursday named Christopher Viehbacher as its new chief executive officer, after a months-long search for a replacement for former CEO Michel Vounatsos.

Viehbacher served as CEO of Sanofi (NASDAQ:) for six years and co-founded life sciences-focused private equity firm Gurnet Point Capital in 2015.

Biogen (NASDAQ:) said in May that Vounatsos would step down amid stalled sales of its controversial Alzheimer’s disease drug Aduhelm.

Vounatsos was the chief executive of the company since 2017.

Copyright © All rights reserved. | Newsphere by AF themes.